Summary: Most newsletters see more good news ahead for ResMed after the sleep apnoea device maker beat analyst forecasts in its first-quarter report, while they are almost unanimous in their belief that childcare centre operator G8 Education’s acquisition strategy will reap more benefits. For 2014-15 softer equity markets may restrict AMP’s growth, weather is likely to be the key swing factor for AGL Energy and future earnings will truly have to be astounding to send Domino’s Pizza Enterprises share price higher, analysts say.
Key take-out: ResMed shares remain a “buy” for most analysts as new product launches propel the company’s revenue in the year ahead.
Key beneficiaries: General investors. Category: Shares.